The gene mutations and subtelomeric DNA methylation in immunodeficiency, centromeric instability and facial anomalies syndrome

References

• Maraschio P, Zuffardi O, Dalla Fior T, et al. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet. 1988;25:173–180.
   PubMed Web of Science ®Google Scholar
• Hansen RS, Wijmenga C, Luo P, et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci USA. 1999;96:14412–14417.
   PubMed Web of Science ®Google Scholar
• de Greef JC, Wang J, Balog J, et al. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet. 2011;88:796–804.
   PubMed Web of Science ®Google Scholar
• Thijssen PE, Ito Y, Grillo G, et al. Mutations in CDCA7 and HELLS cause immunodeficiency-centromeric instability-facial anomalies syndrome. Nat Commun. 2015;6:7870.
   PubMed Web of Science ®Google Scholar
• Chen T, Tsujimoto N, Li E. The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin. Mol Cell Biol. 2004;24:9048–9058.
   PubMed Web of Science ®Google Scholar
• Auclair G, Guibert S, Bender A, et al. Ontogeny of CpG island methylation and specificity of DNMT3 methyltransferases during embryonic development in the mouse. Genome Biol. 2014;15:545.
   PubMed Web of Science ®Google Scholar
• Thompson JJ, Kaur R, Sosa CP, et al. ZBTB24 is a transcriptional regulator that coordinates with DNMT3B to control DNA methylation. Nucleic Acids Res. 2018;46:10034–10051.
   PubMed Web of Science ®Google Scholar
• Wu H, Thijssen PE, de Klerk E, et al. Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals. Hum Mol Genet. 2016;25:4041–4051.
   PubMed Web of Science ®Google Scholar
• Jenness C, Giunta S, Muller MM, et al. HELLS and CDCA7 comprise a bipartite nucleosome remodeling complex defective in ICF syndrome. Proc Natl Acad Sci USA. 2018;115:E876–E885.
   PubMed Web of Science ®Google Scholar
• Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38:23–38.
   PubMed Web of Science ®Google Scholar
• Duan L, Liu Y, Wang J, et al. The dynamic changes of DNA methylation in primordial germ cell differentiation. Gene. 2016;591:305–312.
   PubMed Web of Science ®Google Scholar
• Hu H, Chen X, Zhou C, et al. Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer. J Clin Lab Anal. 2018;32:e22370.
   PubMed Web of Science ®Google Scholar
• Jin B, Tao Q, Peng J, et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Mol Genet. 2008;17:690–709.
   PubMed Web of Science ®Google Scholar
• Gatto S, Gagliardi M, Franzese M, et al. ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing. Nucleic Acids Res. 2017;45:5739–5756.
   PubMed Web of Science ®Google Scholar
• Sagie S, Ellran E, Katzir H, et al. Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome. Hum Mol Genet. 2014;23:3629–3640.
   PubMed Web of Science ®Google Scholar
• Toubiana S, Velasco G, Chityat A, et al. Subtelomeric methylation distinguishes between subtypes of immunodeficiency, centromeric instability and facial anomalies syndrome. Hum Mol Genet. 2018;27:3568–3581.
   PubMed Web of Science ®Google Scholar
• Hu H, Li B, Duan S. The alteration of subtelomeric DNA methylation in aging-related diseases. Front Genet. 2018;9:697
   PubMed Web of Science ®Google Scholar
• Oh BK, Um TH, Choi GH, et al. Frequent changes in subtelomeric DNA methylation patterns and its relevance to telomere regulation during human hepatocarcinogenesis. Int J Cancer. 2011;128:857–868.
   PubMed Web of Science ®Google Scholar
• Upadhyaya M, Lunt PW, Sarfarazi M, et al. DNA marker applicable to presymptomatic and prenatal diagnosis of facioscapulohumeral disease. Lancet. 1990;336:1320–1321.
   PubMed Web of Science ®Google Scholar
• Wijmenga C, Frants RR, Brouwer OF, et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet. 1990;336:651–653.
   PubMed Web of Science ®Google Scholar
• Hansen RS, Stoger R, Wijmenga C, et al. Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. Hum Mol Genet. 2000;9:2575–2587.
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Buchanan KL, Tsien F, et al. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet. 2001;10:2917–2931.
   PubMed Web of Science ®Google Scholar
• Nitta H, Unoki M, Ichiyanagi K, et al. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients. J Hum Genet. 2013;58:455–460.
   PubMed Web of Science ®Google Scholar
• Ehrlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol. 2003;109:17–28.
   PubMed Web of Science ®Google Scholar
• Hagleitner MM, Lankester A, Maraschio P, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet. 2007;45:93–99.
   PubMed Web of Science ®Google Scholar
• Rechavi E, Lev A, Eyal E, et al. A novel mutation in a critical region for the methyl donor binding in DNMT3B causes immunodeficiency, centromeric instability, and facial anomalies syndrome (ICF). J Clin Immunol. 2016;36:801–809.
   PubMed Web of Science ®Google Scholar
• Gimelli G, Varone P, Pezzolo A, et al. ICF syndrome with variable expression in sibs. J Med Genet. 1993;30:429–432.
   PubMed Web of Science ®Google Scholar
• Smeets DF, Moog U, Weemaes CM, et al. ICF syndrome: a new case and review of the literature. Hum Genet. 1994;94:240–246.
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Jackson K, Weemaes C. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis. 2006;1:1–9.
   Web of Science ®Google Scholar
• Franceschini P, Martino S, Ciocchini M, et al. Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anomalies syndrome. Report of two new patients and review of the literature. Eur J Pediatr. 1995;154:840–846.
   PubMed Web of Science ®Google Scholar
• Weemaes CM, van Tol MJ, Wang J, et al. Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet. 2013;21:1219–1225.
   PubMed Web of Science ®Google Scholar
• van den Boogaard ML, Thijssen PE, Aytekin C, et al. Expanding the mutation spectrum in ICF syndrome: evidence for a gender bias in ICF2. Clin Genet. 2017;92:380–387.
   PubMed Web of Science ®Google Scholar
• Gennery AR, Slatter MA, Bredius RG, et al. Hematopoietic stem cell transplantation corrects the immunologic abnormalities associated with immunodeficiency-centromeric instability-facial dysmorphism syndrome. Pediatrics. 2007;120:e1341–1344.
   PubMed Web of Science ®Google Scholar
• Gossling KL, Schipp C, Fischer U, et al. Hematopoietic stem cell transplantation in an infant with immunodeficiency, centromeric instability, and facial anomaly syndrome. Front Immunol. 2017;8:773.
   PubMed Web of Science ®Google Scholar
• Chouery E, Abou-Ghoch J, Corbani S, et al. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Clin Genet. 2012;82:489–493.
   PubMed Web of Science ®Google Scholar
• Herrmann M, Pusceddu I, Marz W, et al. Telomere biology and age-related diseases. Clin Chem Lab Med. 2018;56:1210–1222.
   PubMed Web of Science ®Google Scholar
• Steinert S, Shay JW, Wright WE. Modification of subtelomeric DNA. Mol Cell Biol. 2004;24:4571–4580.
   PubMed Web of Science ®Google Scholar
• Maeda T, Guan JZ, Koyanagi M, et al. Aging-associated alteration of telomere length and subtelomeric status in female patients with Parkinson's disease. J Neurogenet. 2012;26:245–251.
   PubMed Web of Science ®Google Scholar
• Macina RA, Negorev DG, Spais C, et al. Sequence organization of the human chromosome 2q telomere. Hum Mol Genet. 1994;3:1847–1853.
   PubMed Web of Science ®Google Scholar
• Blasco MA. The epigenetic regulation of mammalian telomeres. Nat Rev Genet. 2007;8:299–309.
   PubMed Web of Science ®Google Scholar
• Yehezkel S, Shaked R, Sagie S, et al. Characterization and rescue of telomeric abnormalities in ICF syndrome type I fibroblasts. Front Oncol. 2013;3:35.
   PubMedGoogle Scholar
• Colombel M, Picard A. Prevention of bacillus calmette-guerin immunotherapy complications. Prog Urol. 2008;18:S105–S110.
   PubMed Web of Science ®Google Scholar
• Riethman H, Ambrosini A, Paul S. Human subtelomere structure and variation. Chromosome Res. 2005;13:505–515.
   PubMed Web of Science ®Google Scholar
• Walton EL, Francastel C, Velasco G. Maintenance of DNA methylation: Dnmt3b joins the dance. Epigenetics. 2011;6:1373–1377.
   PubMed Web of Science ®Google Scholar
• Simo-Riudalbas L, Diaz-Lagares A, Gatto S, et al. Genome-wide DNA methylation analysis identifies novel hypomethylated non-pericentromeric genes with potential clinical implications in ICF syndrome. PLoS One. 2015;10:e0132517.
   PubMed Web of Science ®Google Scholar
• Huang K, Wu Z, Liu Z, et al. Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells. Hum Mol Genet. 2014;23:6448–6457.
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Sanchez C, Shao C, et al. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity. 2008;41:253–271.
   PubMed Web of Science ®Google Scholar
• Sagie S, Edni O, Weinberg J, et al. Non-random length distribution of individual telomeres in immunodeficiency, centromeric instability and facial anomalies syndrome, type I. Hum Mol Genet. 2017;26:4244–4256.
   PubMed Web of Science ®Google Scholar
• Sullivan LL, Chew K, Sullivan BA. Alpha-satellite DNA variation and function of the human centromere. Nucleus. 2017;8:331–339.
   PubMed Web of Science ®Google Scholar
• Yehezkel S, Segev Y, Viegas-Pequignot E, et al. Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet. 2008;17:2776–2789.
   PubMed Web of Science ®Google Scholar
• Chu HP, Cifuentes-Rojas C, Kesner B, et al. TERRA RNA antagonizes ATRX and protects telomeres. Cell. 2017;170:86–101 e116.
   PubMed Web of Science ®Google Scholar
• Sagie S, Toubiana S, Hartono SR, et al. Telomeres in ICF syndrome cells are vulnerable to DNA damage due to elevated DNA:RNA hybrids. Nat Commun. 2017;8:14015.
   PubMed Web of Science ®Google Scholar
• Opresko PL, Shay JW. Telomere-associated aging disorders. Ageing Res Rev. 2017;33:52–66.
   PubMed Web of Science ®Google Scholar
• Gonzalo S, Garcia-Cao M, Fraga MF, et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat Cell Biol. 2005;7:420–428.
   PubMed Web of Science ®Google Scholar
• Garcia-Cao M, O'Sullivan R, Peters AH, et al. Epigenetic regulation of telomere length in mammalian cells by the Suv39h1 and Suv39h2 histone methyltransferases. Nat Genet. 2004;36:94–99.
   PubMed Web of Science ®Google Scholar
• Garcia-Cao M, Gonzalo S, Dean D, et al. A role for the Rb family of proteins in controlling telomere length. Nat Genet. 2002;32:415–419.
   PubMed Web of Science ®Google Scholar
• Guan JZ, Guan WP, Maeda T, et al. Analysis of telomere length and subtelomeric methylation of circulating leukocytes in women with Alzheimer's disease. Aging Clin Exp Res. 2013;25:17–23.
   PubMed Web of Science ®Google Scholar
• Lee ME, Rha SY, Jeung HC, et al. Subtelomeric DNA methylation and telomere length in human cancer cells. Cancer Lett. 2009;281:82–91.
   PubMed Web of Science ®Google Scholar
• Gonzalo S, Jaco I, Fraga MF, et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol. 2006;8:416–424.
   PubMed Web of Science ®Google Scholar
• Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev. 2008;88:557–579.
   PubMed Web of Science ®Google Scholar
• Kamae C, Imai K, Kato T, et al. Clinical and immunological characterization of ICF syndrome in Japan. J Clin Immunol. 2018;38:927–937.
   PubMed Web of Science ®Google Scholar
• Carpenter NJ, Filipovich A, Blaese RM, et al. Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16. J Pediatr. 1988;112:757–760.
   PubMed Web of Science ®Google Scholar
• Hu SC, Wang YB, Sun Q, et al. Clinical and genetic manifestations of immunodeficiency, centromeric instability, and facial anomalies syndrome: a case report and literature review. Zhonghua Er Ke Za Zhi. 2019;57:55–59.
   PubMedGoogle Scholar
• Sterlin D, Velasco G, Moshous D, et al. Genetic, cellular and clinical features of ICF syndrome: a french national survey. J Clin Immunol. 2016;36:149–159.
   PubMed Web of Science ®Google Scholar
• Schuffenhauer S, Bartsch O, Stumm M, et al. DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum Genet. 1995;96:562–571.
   PubMed Web of Science ®Google Scholar
• Tiepolo L, Maraschio P, Gimelli G, et al. Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency. Hum Genet. 1979;51:127–137.
   PubMed Web of Science ®Google Scholar
• Shirohzu H, Kubota T, Kumazawa A, et al. Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am J Med Genet. 2002;112:31–37.
   PubMed Web of Science ®Google Scholar
• Bjorck EJ, Bui TH, Wijmenga C, et al. Early prenatal diagnosis of the ICF syndrome. Prenat Diagn. 2000;20:828–831.
   PubMedGoogle Scholar
• Rigolet M, Gregoire A, Lefort G, et al. Early prenatal diagnosis of ICF syndrome by mutation detection. Prenat Diagn. 2007;27:1075–1078.
   PubMed Web of Science ®Google Scholar
• Kaya N, Al-Muhsen S, Al-Saud B, et al. ICF syndrome in Saudi Arabia: immunological, cytogenetic and molecular analysis. J Clin Immunol. 2011;31:245–252.
   PubMed Web of Science ®Google Scholar
• Kutlug S, Ogur G, Yilmaz A, et al. Vesicourethral reflux-induced renal failure in a patient with ICF syndrome due to a novel DNMT3B mutation. Am J Med Genet.. 2016;170:3253–3257.
   PubMed Web of Science ®Google Scholar
• Conrad MA, Dawany N, Sullivan KE, et al. Novel ZBTB24 mutation associated with immunodeficiency, centromere instability, and facial anomalies type-2 syndrome identified in a patient with very early onset inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:2252–2255.
   PubMed Web of Science ®Google Scholar
• Cerbone M, Wang J, Van der Maarel SM, et al. Immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome, due to ZBTB24 mutations, presenting with large cerebral cyst. Am J Med Genet. 2012;158A:2043–2046.
   PubMed Web of Science ®Google Scholar